
Molecular Partners AG
MOLN160.82MMarket Cap
LossP/E TTM
MOLN Balance Sheet
You can check out the annual or quarterly balance sheets of Molecular Partners AG here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing MOLN stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Molecular Partners AG Have?
In its most recent quarterly, Molecular Partners AG had 84.76M in cash and cash equivalents.
How Much Are Molecular Partners AG's Total Liabilities?
Molecular Partners AG reported 27.52M in total liabilities as of the latest reported quarter, including 13.94M in current liabilities and 13.58M in non-current liabilities.
What Are Molecular Partners AG's Total Assets?
As of the latest reported quarter, Molecular Partners AG's total assets were 129.05M, consisting of 122.44M in current assets and 6.61M in non-current assets.
How Much Shareholders' Equity Does Molecular Partners AG Have?
Molecular Partners AG reported 101.53M in total shareholders' equity as of the latest reported quarter.